Related Experiment Video
Updated: Jan 18, 2026
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Pneumonia, a pulmonary abscess, and an empyema caused by Parvimonas micra
Yuxiang Li1, Xia Wang2, Lidi Zhang3
1Department of Critical Care Medicine, People's Hospital Yongdeng, Lanzhou, Gansu Province, China.
Background:
Pneumonia with an empyema caused by anaerobic bacteria is rare but can be life-threatening, especially in immunocompromised patients.
Case Presentation:
A 67-year-old man with diabetes and hypertension who presented with pneumonia and pleural effusion and was unresponsive to initial broad-spectrum antibiotics is presented. Next-generation sequencing identified Parvimonas micra and other pathogens. Therefore, targeted therapy with levornidazole was initiated. The patient's condition improved significantly after this treatment.
Conclusions:
This case highlights the importance of considering anaerobic bacteria in immunocompromised patients and the utility of next-generation sequencing in identifying atypical pathogens.
Insights
Anaerobic bacteria, like Parvimonas micra, can cause severe pneumonia with empyema in immunocompromised individuals. Next-generation sequencing aided in identifying the pathogen, leading to effective targeted therapy with levornidazole.
Area of Science:
- Infectious Diseases
- Microbiology
- Pulmonology
Background:
- Anaerobic bacterial pneumonia with empyema is a rare but serious condition.
- Immunocompromised patients are at higher risk for severe outcomes.
Purpose of the Study:
- To report a case of anaerobic pneumonia with empyema.
- To highlight the diagnostic utility of next-generation sequencing (NGS).
- To demonstrate the effectiveness of targeted antibiotic therapy.
Main Methods:
- Case presentation of a 67-year-old male with diabetes and hypertension.
- Initial broad-spectrum antibiotics were ineffective.
- Next-generation sequencing (NGS) was employed for pathogen identification.
- Targeted therapy with levornidazole was initiated.
Main Results:
- Next-generation sequencing identified Parvimonas micra as a causative agent.
- The patient showed significant clinical improvement after targeted levornidazole therapy.
Conclusions:
- Anaerobic bacteria should be considered in immunocompromised patients with pneumonia and empyema.
- Next-generation sequencing (NGS) is a valuable tool for identifying challenging pathogens.
- Prompt and targeted therapy can lead to favorable patient outcomes.
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia III: Complications and Assessment
01:29Pneumonia II: Pathophysiology
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:15Diversity of Protists I